Overview of Selank 5mg Research Compound
Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin, enhanced with a C-terminal Pro-Gly-Pro tripeptide sequence. This nootropic compound represents an advancement in peptide research, originally developed at the Institute of Molecular Genetics in Russia. Researchers examining neurochemical pathways will find Selank’s unique molecular structure provides opportunities to investigate GABAergic neurotransmission, inflammatory cytokine modulation, and cognitive enhancement mechanisms in laboratory settings.
The compound demonstrates high stability and bioavailability in preclinical models, making it suitable for extended research protocols. Scientists at Stroid UK Shop utilise this peptide to study anxiolytic pathways and neuroplasticity mechanisms. Researchers exploring Selank peptide compounds can examine its interactions with various neurotransmitter systems alongside other research chemicals from our SARMs collection and comprehensive peptides catalogue.
Laboratory Research Applications
Selank enables comprehensive investigation of neurochemical pathways and immunomodulatory responses in controlled laboratory environments. Research applications include examining IL-6 cytokine regulation, studying BDNF expression modulation, and analysing GABA receptor interactions in neural tissue models. The compound’s anxiolytic properties make it valuable for stress response research, while its nootropic characteristics support cognitive enhancement studies.
Investigators can examine Selank’s effects on learning and memory consolidation pathways, explore its potential neuroprotective mechanisms, and study its influence on neurotransmitter balance. The peptide’s immunomodulatory properties provide research opportunities in neuroinflammation studies and stress-induced immune response investigations.
Product Specifications
| Parameter | Value |
|---|---|
| CAS Number | 129954-34-3 |
| Molecular Formula | C₃₃H₅₇N₁₁O₉ |
| Molecular Weight | 751.87 g/mol |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Purity | ≥98% (HPLC verified) |
| Storage | 2-8°C, protect from light |
| Manufacturer | Beligas Pharmaceuticals |
| Form | Lyophilised powder |
Research Compliance Statement
This Selank 5mg product is manufactured exclusively for in-vitro laboratory research applications and scientific investigation purposes. The compound is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure compliance with institutional guidelines and maintain appropriate laboratory safety protocols when handling this research chemical. All studies should be conducted in controlled laboratory environments with proper documentation and safety measures.
